5-Chloro-2-methylpyridine

Catalog No.: 
ACAVTC384
CAS No.: 
72093-07-3
Molecular Formula: 
C6H6ClN
Molecular Weight: 
127.57
5-Chloro-2-methylpyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g98%$101.00In stockInquiry
100g98%$404.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Chloro-2-methylpyridine
IUPAC Name5-chloro-2-methylpyridine
MDL No.MFCD04114188
Molecular FormulaC6H6ClN
Molecular Weight127.57
SMILESCC1=NC=C(Cl)C=C1
InChI KeyDEMKNLXJQNYAFY-UHFFFAOYSA-N
Synonym5-chloro-2-methylpyridine | 72093-07-3 | 5-Chloro-2-picoline | 2-METHYL-5-CHLOROPYRIDINE | MFCD04114188 | PYRIDINE, 5-CHLORO-2-METHYL- | 5-chloro-2-methyl-pyridine | SCHEMBL111140 | AMY6284 | DTXSID10376526 | DEMKNLXJQNYAFY-UHFFFAOYSA-N | BBL101715 | STL555512 | AKOS006228306 | AB17
CAS No.72093-07-3
PubChem CID2762869

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACAVTC384 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNYFL503 route compound structure diagram
    ACNYFL50316110-09-1In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAVTC384 route product structure diagram
    ACAVTC38472093-07-3In Stock
Inquiry

2. ACAVTC384 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACSHYG392 route compound structure diagram
    ACSHYG392209526-98-7In Stock
  2. Then
  3. ACAVTC384 route product structure diagram
    ACAVTC38472093-07-3In Stock
Inquiry

3. ACAVTC384 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLREB347 route compound structure diagram
    ACLREB347124425-84-9In Stock
  2. Then
  3. ACAVTC384 route product structure diagram
    ACAVTC38472093-07-3In Stock
Inquiry

Comments (0)